Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 January 2008:
Vol. 319. no. 5860, pp. 195 - 198
DOI: 10.1126/science.1150224
Prev | Table of Contents | Next

Reports

Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis

Dingcheng Gao, Daniel J. Nolan, Albert S. Mellick, Kathryn Bambino, Kevin McDonnell, Vivek Mittal*

Angiogenesis-mediated progression of micrometastasis to lethal macrometastasis is the major cause of death in cancer patients. Here, using mouse models of pulmonary metastasis, we identify bone marrow (BM)–derived endothelial progenitor cells (EPCs) as critical regulators of this angiogenic switch. We show that tumors induce expression of the transcription factor Id1 in the EPCs and that suppression of Id1 after metastatic colonization blocked EPC mobilization, caused angiogenesis inhibition, impaired pulmonary macrometastases, and increased survival of tumor-bearing animals. These findings establish the role of EPCs in metastatic progression in preclinical models and suggest that selective targeting of EPCs may merit investigation as a therapy for cancer patients with lung metastases.

Cancer Genome Research Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.

* To whom correspondence should be addressed. E-mail: mittal{at}cshl.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis.
R. C. Doebele, F. T. Schulze-Hoepfner, J. Hong, A. Chlenski, B. D. Zeitlin, K. Goel, S. Gomes, Y. Liu, M. K. Abe, J. E. Nor, et al. (2009)
Blood 114, 4592-4600
   Abstract »    Full Text »    PDF »
Suppression of Tumor Angiogenesis by G{alpha}13 Haploinsufficiency.
L. Chen, J. J. Zhang, S. Rafii, and X.-Y. Huang (2009)
J. Biol. Chem. 284, 27409-27415
   Abstract »    Full Text »    PDF »
Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models.
L. G. Daenen, Y. Shaked, S. Man, P. Xu, E. E. Voest, R. M. Hoffman, D. J. Chaplin, and R. S. Kerbel (2009)
Mol. Cancer Ther. 8, 2872-2881
   Abstract »    Full Text »    PDF »
Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1.
C. Folkins, Y. Shaked, S. Man, T. Tang, C. R. Lee, Z. Zhu, R. M. Hoffman, and R. S. Kerbel (2009)
Cancer Res. 69, 7243-7251
   Abstract »    Full Text »    PDF »
Blockade of Wnt Signaling Inhibits Angiogenesis and Tumor Growth in Hepatocellular Carcinoma.
J. Hu, A. Dong, V. Fernandez-Ruiz, J. Shan, M. Kawa, E. Martinez-Anso, J. Prieto, and C. Qian (2009)
Cancer Res. 69, 6951-6959
   Abstract »    Full Text »    PDF »
Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche.
H. C. Suh, M. Ji, J. Gooya, M. Lee, K. D. Klarmann, and J. R. Keller (2009)
Blood 114, 1186-1195
   Abstract »    Full Text »    PDF »
Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1.
S.-Y. Kang, O. J. Halvorsen, K. Gravdal, N. Bhattacharya, J. M. Lee, N. W. Liu, B. T. Johnston, A. B. Johnston, S. A. Haukaas, K. Aamodt, et al. (2009)
PNAS 106, 12115-12120
   Abstract »    Full Text »    PDF »
High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies.
M. Taylor, J. Rossler, B. Geoerger, A. Laplanche, O. Hartmann, G. Vassal, and F. Farace (2009)
Clin. Cancer Res. 15, 4561-4571
   Abstract »    Full Text »    PDF »
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
A. Reinisch, N. A. Hofmann, A. C. Obenauf, K. Kashofer, E. Rohde, K. Schallmoser, K. Flicker, G. Lanzer, W. Linkesch, M. R. Speicher, et al. (2009)
Blood 113, 6716-6725
   Abstract »    Full Text »    PDF »
Targeting Tumor Endothelial Marker 8 in the Tumor Vasculature of Colorectal Carcinomas in Mice.
S. Fernando and B. S. Fletcher (2009)
Cancer Res. 69, 5126-5132
   Abstract »    Full Text »    PDF »
White Adipose Tissue Cells Are Recruited by Experimental Tumors and Promote Cancer Progression in Mouse Models.
Y. Zhang, A. Daquinag, D. O. Traktuev, F. Amaya-Manzanares, P. J. Simmons, K. L. March, R. Pasqualini, W. Arap, and M. G. Kolonin (2009)
Cancer Res. 69, 5259-5266
   Abstract »    Full Text »    PDF »
Stem Cells and the Natural History of Lung Cancer: Implications for Lung Cancer Screening.
R. J. van Klaveren, S. C. van't Westeinde, B.-J. de Hoop, and H. C. Hoogsteden (2009)
Clin. Cancer Res. 15, 2215-2218
   Abstract »    Full Text »    PDF »
Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.
H. Chen, R. A. Campbell, Y. Chang, M. Li, C. S. Wang, J. Li, E. Sanchez, M. Share, J. Steinberg, A. Berenson, et al. (2009)
Blood 113, 1992-2002
   Abstract »    Full Text »    PDF »
Endothelial progenitor cell homing: prominent role of the IGF2-IGF2R-PLC{beta}2 axis.
Y.-S. Maeng, H.-J. Choi, J.-Y. Kwon, Y.-W. Park, K.-S. Choi, J.-K. Min, Y.-H. Kim, P.-G. Suh, K.-S. Kang, M.-H. Won, et al. (2009)
Blood 113, 233-243
   Abstract »    Full Text »    PDF »
TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche.
M. Yamamoto, H. Kikuchi, M. Ohta, T. Kawabata, Y. Hiramatsu, K. Kondo, M. Baba, K. Kamiya, T. Tanaka, M. Kitagawa, et al. (2008)
Cancer Res. 68, 9754-9762
   Abstract »    Full Text »    PDF »
Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression.
M. Aleku, P. Schulz, O. Keil, A. Santel, U. Schaeper, B. Dieckhoff, O. Janke, J. Endruschat, B. Durieux, N. Roder, et al. (2008)
Cancer Res. 68, 9788-9798
   Abstract »    Full Text »    PDF »
Combination of antiangiogenesis with chemotherapy for more effective cancer treatment.
J. Ma and D. J. Waxman (2008)
Mol. Cancer Ther. 7, 3670-3684
   Abstract »    Full Text »    PDF »
Cancer Stem Cells and Bone Metastasis.
G. J. Strewler (2008)
IBMS BoneKEy 5, 308-322
   Abstract »    Full Text »    PDF »
Endothelial progenitor cells are cellular hubs essential for neoangiogenesis of certain aggressive adenocarcinomas and metastatic transition but not adenomas.
R. S. Kerbel, R. Benezra, D. C. Lyden, K. Hattori, B. Heissig, D. J. Nolan, V. Mittal, Y. Shaked, S. Dias, F. Bertolini, et al. (2008)
PNAS 105, E54
   Full Text »    PDF »
Reply to Kerbel et al.: EPCs are again claimed to be essential in yet other models despite the irreproducibility of the original experiments introducing them.
P. Salven, S. Purhonen, D. Rossi, S. Yla-Herttuala, K. Alitalo, and I. L. Weissman (2008)
PNAS 105, E55
   Full Text »    PDF »
17{beta}-Estradiol Mobilizes Bone Marrow-Derived Endothelial Progenitor Cells to Tumors.
R. Suriano, D. Chaudhuri, R. S. Johnson, E. Lambers, B. T. Ashok, R. Kishore, and R. K. Tiwari (2008)
Cancer Res. 68, 6038-6042
   Abstract »    Full Text »    PDF »
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
R. G. Bagley, C. Rouleau, T. St. Martin, P. Boutin, W. Weber, M. Ruzek, N. Honma, M. Nacht, S. Shankara, S. Kataoka, et al. (2008)
Mol. Cancer Ther. 7, 2536-2546
   Abstract »    Full Text »    PDF »
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases.
D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop (2008)
Proceedings of the ATS 5, 637-667
   Full Text »    PDF »
Review: Endothelial progenitor cells: markers of vascular reparative capacity.
T. J. Povsic and P. J. Goldschmidt-Clermont (2008)
Therapeutic Advances in Cardiovascular Disease 2, 199-213
   Abstract »    PDF »
Tumor Angiogenesis.
R. S. Kerbel (2008)
N. Engl. J. Med. 358, 2039-2049
   Full Text »    PDF »
Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
S. Purhonen, J. Palm, D. Rossi, N. Kaskenpaa, I. Rajantie, S. Yla-Herttuala, K. Alitalo, I. L. Weissman, and P. Salven (2008)
PNAS 105, 6620-6625
   Abstract »    Full Text »    PDF »
Migratory neighbors and distant invaders: tumor-associated niche cells.
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden (2008)
Genes & Dev. 22, 559-574
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)